铁蛋白对多发性骨髓瘤诊断中的临床意义

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (712 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the clinical significance of serum ferritin (SF) in patients who were diagnosed with multiple myeloma (MM).Methods Thirty-two newly-diagnosed MM patients treated in the Department of Hematology of Shanghai Tenth Hospital between January 2016 and June 2018 were enrolled in the MM group, while another 39 healthy volunteers were assigned to the normal control group in the same period of time. Other factors that could increase levels of SF were excluded in the MM group. The levels of SF of the two groups were detected to find out whether there was statistically significant difference between the two groups. The diagnostic value of SF in MM patients was determined by the ROC curve. SF levels and related levels of β₂-microglobulin (β₂-MG) and lactate dehydrogenase (LDH) before each cycle of chemotherapy in the MM group were followed up totally for 169 person-times, and statistical analysis was performed. The value of SF at different stages of MM patients was further analyzed.Results The levels of SF in the 32 patients with MM (546.60±427.66) ng/ml were significantly higher than those of normal controls (231.20±111.70)ng/ml (P=0.000). In the ROC curve analysis, the area under the SF level curve was 0.75 (P=0.000), which was of diagnostic significance. According to the levels of SF, β₂-MG and LDH in MM patients before each cycle of chemotherapy, it was found that there was a positive correlation between SF levels and β₂-MG levels (r=0.714, P<0.01), but no significant correlation with LDH levels (r=0.059, P>0.05). SF levels in stage Ⅲ MM patients were significantly higher than those in stage Ⅰ and stage Ⅱ MM patients (P<0.05).Conclusions SF is of diagnostic value for MM, which can reflect tumor burden to some extent. SF combined with β₂-MG can facilitate staging and prognosis of multiple myeloma.

Key words： multiple myeloma serum ferritin β2-Microglobulin lactic dehydrogenase

Received: 23 June 2018

ZTFLH:

R446.11

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Xiaoying
	YU Qing
	and TAO Yi

Cite this article:

WU Xiaoying,YU Qing,and TAO Yi. Diagnostic value of serum ferritin in patients diagnosed with multiple myeloma[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2018, 29(12): 1144-1147.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2018/V29/I12/1144

[1]	Eslick R, Talaulikar D. Multiple myeloma: from diagnosis to treatment [J]. Aust Fam Physician, 2013, 42(10): 684-688.
[2]	Caers J, Withofs N, Hillengass J, et al. The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma [J]. Haematologica, 2014, 99(4): 629-637.
[3]	刘汐盈,孙淑艳,宋媛媛. 血清免疫固定电泳、蛋白电泳、免疫球蛋白及轻链定量对多发性骨髓瘤临床诊断价值探讨[J]. 中国实验诊断学, 2010, 14(5): 680-681.
[4]	王淑君,高冲,陈宝安. 肿瘤细胞铁代谢及其调节研究进展[J].癌症, 2010, 29(4): 500-504.
[5]	赵晓华.血清铁蛋白在恶性血液病诊断与治疗中的价值[J]. 实用临床医学, 2014,15(12): 7-9.
[6]	Song M K, Chung J S, Seol Y M, et al. Elevation of serum ferritin is associated with the outcome of patients with newly diagnosed multiple myeloma[J]. Korean J Intern Med, 2009, 24(4): 368-373.
[7]	郭艳. 检测血清铁蛋白、IL-10在多发性骨髓瘤中的意义[J]. 世界最新医学信息文摘, 2015, 15(9): 89-90.
[8]	Shimoni A. Risk stratification of patients with multiple myeloma prior to autologous stem cell transplant: what is the role of serum ferritin levels? [J]. Leuk Lymphoma, 2014, 55(11): 2419-2420.
[9]	Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in Globocan 2012[J]. Int J Cancer, 2015, 136(5): E359-E386.
[10]	杨蕊雪,高露,施菊妹. 多发性骨髓瘤的诊断进展与分期[J]. 中国癌症杂志, 2014, 24 (10):727-731.
[11]	刘丽辉,曹履先. 铁蛋白的临床应用[J]. 临床荟萃, 2011, 26(3): 437-441.
[12]	Li Y, Guan Q, Chen Y, et al. Transferrrin receptor and ferritin-H are developmentally regulated in oligodendrocyte lineage cells [J].Neural Regen Res, 2013, 8(1):6-12.
[13]	程玉萍.血清铁蛋白检测在临床应用的研究进展[J]. 山西医药杂志(下半月版), 2013, 42(6): 639-640.
[14]	李世生.肿瘤相关糖类抗原CA125、CA153、Fer联合测定对卵巢肿瘤的诊断价值[J]. 广西医科大学学报, 2009, 26(6): 889-890.
[15]	李琼芬.血清Fer联合4种肿瘤标记物对肺癌的诊断价值[J].海南医学院学报,2012,18(2): 171-174.
[16]	周云英,辜红妮,郑庭亮.血清CEA、CA199、SF联合检测在胃癌中的临床价值[J].国际检验医学杂志,2010, 31(4): 345-346.
[17]	Lam P V N, Goldman R, Karagiannis K, et al. Structure-based comparative analysis and prediction of N-linked glycosylation sites in evolutionarily distant eukaryotes [J]. Genom Proteom Bioinf, 2013, 11(2): 96-104.
[18]	王海颖,李永伟. 血清叶酸、铁蛋白监测在多发性骨髓瘤诊治中的价值研究[J]. 中国现代医学杂志, 2016, 26(19): 117-119.
[19]	彭又生,陈伟彦,陈思颖.多发性骨髓瘤患者铁蛋白检测及临床意义[J].齐齐哈尔医学院学报,2014, 35(1): 10-11.
[20]	Alkhateeb A A, Han B, Connor J R. Ferritin stimulate breast cancer cells through an iron-independent mechanism and in localized within tumor-associated macrophages [J]. Breast Cancer Res Treat, 2013, 137(3): 733-744.
[21]	Alkhateeb A A, Connor J R. The significance of ferritin in cancer: Antioxidation, inflammation and tumorigenesis[J]. Biochim Biophys Acta, 2013, 1836(2): 245-254.
[22]	Kalousová M, Krechler T, Jáchymová M, et al. Ferritin as an independent mortality predictor in patients with pancreas cancers. Results of a pilot study [J]. Tumor Biol, 2012, 33(5): 1695-1700.
[23]	王亚辉, 崔娜, 沈江萍.β2-微球蛋白测定的临床应用[J]. 齐齐哈尔医学院学报, 2013, 31(8): 1271-1272.
[24]	耿传营,陈文明.《中国多发性骨髓瘤诊治指南(2015年修订)》治疗部分解读[J]. 临床血液学杂志,2016, 29(6): 923-926.